Bronchodilators are front-line weapons against asthma and chronic obstructive pulmonary disorder. The search continues for ...

Physicians can use peak expiratory flow as a first-line tool for assessing variable airflow limitations among patients with ...

Background: A limited or absent bronchodilator response is used to classify chronic obstructive pulmonary disease (COPD) and can determine the treatment offered. The reliability of the recommended ...

1 UBC James Hogg Research Laboratories, Providence Heart and Lung Institute, St Paul's Hospital, University of British Columbia, Vancouver, Canada Rationale Criteria for a clinically significant ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

Australia’s new asthma guidelines warn against anyone with asthma – even those with infrequent symptoms – using only salbutamol inhaler.

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...

Tezepelumab, a monoclonal antibody targeting TSLP approved for add-on severe asthma treatment in 2021, had been associated ...

BACKGROUND Salbutamol is frequently used as a bronchodilator for infants who wheeze. Many single dose studies have questioned its effectiveness. AIMS To investigate the response of wheezy infants to ...

We recently published a list of Jim Cramer Put These 14 Stocks Under the Microscope. In this article, we are going to take a ...

AstraZeneca presented data from the phase 3 BATURA study which showed that use of Airsupra in those with mild asthma reduced ...